E van Puijenbroek
E van Puijenbroek
Hoogleraar geneesmiddelenbewaking en geneesmiddelenveiligheid
Geverifieerd e-mailadres voor home.nl
Titel
Geciteerd door
Geciteerd door
Jaar
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
EP van Puijenbroek, A Bate, HGM Leufkens, M Lindquist, R Orre, ...
Pharmacoepidemiology and drug safety 11 (1), 3-10, 2002
7162002
The role of data mining in pharmacovigilance
M Hauben, D Madigan, CM Gerrits, L Walsh, EP Van Puijenbroek
Expert opinion on drug safety 4 (5), 929-948, 2005
2722005
Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry
T Tomson, D Battino, E Bonizzoni, J Craig, D Lindhout, E Perucca, ...
The Lancet Neurology 17 (6), 530-538, 2018
2082018
Guidelines for submitting adverse event reports for publication
WN Kelly, FM Arellano, J Barnes, U Bergman, IR Edwards, AM Fernandez, ...
Pharmacoepidemiology and drug safety 16 (5), 581-587, 2007
1732007
Use of measures of disproportionality in pharmacovigilance
ACG Egberts, RHB Meyboom, EP van Puijenbroek
Drug safety 25 (6), 453-458, 2002
1702002
Application of quantitative signal detection in the Dutch spontaneous reporting system for adverse drug reactions
EP Van Puijenbroek, WL Diemont, K van Grootheest
Drug Safety 26 (5), 293-301, 2003
1542003
Tendon disorders attributed to fluoroquinolones: a study on 42 spontaneous reports in the period 1988 to 1998
PD Van Der Linden, EP Van Puijenbroek, J Feenstra, BA In ‘T Veld, ...
Arthritis Care & Research: Official Journal of the American College of …, 2001
1542001
Downregulation of the posterior medial frontal cortex prevents social conformity
V Klucharev, MAM Munneke, A Smidts, G Fernández
Journal of Neuroscience 31 (33), 11934-11940, 2011
1492011
Drug-associated acute pancreatitis: twenty-one years of spontaneous reporting in The Netherlands
IA Eland, EP Van Puijenbroek, M Sturkenboom, JHP Wilson, BHC Stricker
The American journal of gastroenterology 94 (9), 2417-2422, 1999
1421999
On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under‐reporting on odds ratios
PGM van der Heijden, EP van Puijenbroek, S van Buuren, ...
Statistics in medicine 21 (14), 2027-2044, 2002
1382002
Dose-dependent teratogenicity of valproate in mono-and polytherapy: an observational study
T Tomson, D Battino, E Bonizzoni, J Craig, D Lindhout, E Perucca, ...
Neurology 85 (10), 866-872, 2015
1262015
Signalling possible drug–drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole
EP Van Puijenbroek, ACG Egberts, RHB Meyboom, HGM Leufkens
British journal of clinical pharmacology 47 (6), 689-693, 1999
1171999
Detecting drug–drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs
EP van Puijenbroek, ACG Egberts, ER Heerdink, HGM Leufkens
European journal of clinical pharmacology 56 (9), 733-738, 2000
1142000
Contribution of pharmacists to the reporting of adverse drug reactions
AC Van Grootheest, EP Van Puijenbroek, LTW de Jong–van den Berg
Pharmacoepidemiology and drug safety 11 (3), 205-210, 2002
1022002
Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case–control study using spontaneous reports
I Schillevoort, EP Van Puijenbroek, A de Boer, RAC Roos, PAF Jansen, ...
International clinical psychopharmacology 17 (2), 75-79, 2002
1012002
Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
F van Hunsel, C van der Welle, A Passier, E van Puijenbroek, ...
European journal of clinical pharmacology 66 (11), 1143-1150, 2010
772010
The reporting odds ratio versus the proportional reporting ratio:'deuce'.
P Waller, EP Van Puijenbroek, ACG Egberts, S Evans
Pharmacoepidemiology and drug safety 13 (8), 525-526, 2004
722004
Determinants of signal selection in a spontaneous reporting system for adverse drug reactions
EP Van Puijenbroek, K Van Grootheest, WL Diemont, HGM Leufkens, ...
British journal of clinical pharmacology 52 (5), 579-586, 2001
692001
Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil
EP Van Puijenbroek, PWG DU BUF‐VEREIJKEN, P Spooren, ...
Journal of internal medicine 240 (6), 403-404, 1996
691996
Hyponatraemia as an adverse drug reaction of antipsychotic drugs
CK Mannesse, EP Van Puijenbroek, PAF Jansen, RJ Van Marum, ...
Drug safety 33 (7), 569-578, 2010
662010
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20